Berlan M[au] - Search Results

Year	Number of Results
1970	1
1971	1
1972	1
1974	1
1975	1
1976	2
1977	2
1978	2
1979	1
1980	4
1981	7
1982	3
1983	5
1984	2
1985	5
1986	3
1987	4
1988	4
1989	12
1990	14
1991	8
1992	5
1993	8
1994	4
1995	8
1996	4
1997	7
1998	10
1999	9
2000	6
2001	6
2002	7
2003	9
2004	4
2005	8
2006	6
2007	7
2008	3
2009	2
2010	3
2011	1
2012	1
2022	0

1

Pregnancy modifies the alpha2-beta-adrenergic receptor functional balance in rabbit fat cells.

Bousquet-Mélou A, Muñoz C, Galitzky J, Berlan M, Lafontan M. Bousquet-Mélou A, et al. Among authors: berlan m. J Lipid Res. 1999 Feb;40(2):267-74. J Lipid Res. 1999. PMID: 9925656 Free article.

2

Influence of development and reduction of fat stores on the antilipolytic alpha 2-adrenoceptor in hamster adipocytes: comparison with adenosine and beta-adrenergic lipolytic responses.

Carpene C, Berlan M, Lafontan M. Carpene C, et al. Among authors: berlan m. J Lipid Res. 1983 Jun;24(6):766-74. J Lipid Res. 1983. PMID: 6310014 Free article.

3

Cardiovascular and metabolic effects of natriuretic peptides.

Moro C, Berlan M. Moro C, et al. Among authors: berlan m. Fundam Clin Pharmacol. 2006 Feb;20(1):41-9. doi: 10.1111/j.1472-8206.2005.00379.x. Fundam Clin Pharmacol. 2006. PMID: 16448393 Review.

4

Adrenergic regulation of adipocyte metabolism.

Lafontan M, Barbe P, Galitzky J, Tavernier G, Langin D, Carpéné C, Bousquet-Melou A, Berlan M. Lafontan M, et al. Among authors: berlan m. Hum Reprod. 1997 Oct;12 Suppl 1:6-20. doi: 10.1093/humrep/12.suppl_1.6. Hum Reprod. 1997. PMID: 9403317 Review.

5

Beta 3-adrenoceptors in the cardiovascular system.

Berlan M, Galitzky J, Montastruc JL. Berlan M, et al. Fundam Clin Pharmacol. 1995;9(3):234-9. doi: 10.1111/j.1472-8206.1995.tb00290.x. Fundam Clin Pharmacol. 1995. PMID: 7557818 Review.

6

Control of lipolysis by natriuretic peptides and cyclic GMP.

Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J. Lafontan M, et al. Among authors: berlan m. Trends Endocrinol Metab. 2008 May-Jun;19(4):130-7. doi: 10.1016/j.tem.2007.11.006. Epub 2008 Mar 11. Trends Endocrinol Metab. 2008. PMID: 18337116 Review.

7

Physiological regulation of NEFA availability: lipolysis pathway.

Stich V, Berlan M. Stich V, et al. Among authors: berlan m. Proc Nutr Soc. 2004 May;63(2):369-74. doi: 10.1079/PNS2004350. Proc Nutr Soc. 2004. PMID: 15294057 Review.

8

Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy.

Berlan M, Montastruc JL, Lafontan M. Berlan M, et al. Trends Pharmacol Sci. 1992 Jul;13(7):277-82. doi: 10.1016/0165-6147(92)90085-k. Trends Pharmacol Sci. 1992. PMID: 1354903 Review.

9

Do regional differences in adipocyte biology provide new pathophysiological insights?

Lafontan M, Berlan M. Lafontan M, et al. Among authors: berlan m. Trends Pharmacol Sci. 2003 Jun;24(6):276-83. doi: 10.1016/S0165-6147(03)00132-9. Trends Pharmacol Sci. 2003. PMID: 12823953 Review.

10

Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis.

Lafontan M, Berlan M. Lafontan M, et al. Among authors: berlan m. Endocr Rev. 1995 Dec;16(6):716-38. doi: 10.1210/edrv-16-6-716. Endocr Rev. 1995. PMID: 8747832 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results